216 related articles for article (PubMed ID: 19133361)
61. Reducing the risks of gastrointestinal bleeding with antiplatelet therapies.
Cryer B
N Engl J Med; 2005 Jan; 352(3):287-9. PubMed ID: 15659730
[No Abstract] [Full Text] [Related]
62. Empirical trials in treatment of gastroesophageal reflux disease.
Fass R
Dig Dis; 2000; 18(1):20-6. PubMed ID: 10729734
[TBL] [Abstract][Full Text] [Related]
63. Acid reflux in patients with coronary artery disease and refractory chest pain.
Liu Y; He S; Chen Y; Xu J; Tang C; Tang Y; Luo G
Intern Med; 2013; 52(11):1165-71. PubMed ID: 23728549
[TBL] [Abstract][Full Text] [Related]
64. Gastroesophageal reflux disease and childhood asthma.
Blake K; Teague WG
Curr Opin Pulm Med; 2013 Jan; 19(1):24-9. PubMed ID: 23197288
[TBL] [Abstract][Full Text] [Related]
65. High-dose omeprazole in patients with noncardiac chest pain.
Friedel D; Ozick LA
Gastroenterology; 1999 Jan; 116(1):226-7. PubMed ID: 9869626
[No Abstract] [Full Text] [Related]
66. It is difficult to discontinue PPI treatment in patients with GERD.
Bjornsson E
Am J Gastroenterol; 2011 Feb; 106(2):367-8; author reply 368. PubMed ID: 21301460
[No Abstract] [Full Text] [Related]
67. [Efficacy and tolerability of pantoprazole in the treatment of gastroesophageal reflux disease].
Gillessen A
MMW Fortschr Med; 2010 May; 152(18):52. PubMed ID: 20514766
[No Abstract] [Full Text] [Related]
68. [Decreased need for tablets with pantoprazole. PPI: independent study questions savings through use of generic drugs].
MMW Fortschr Med; 2007 Dec; 149(49-50):58. PubMed ID: 18236985
[No Abstract] [Full Text] [Related]
69. Eosinophilic esophagitis and gastroesophageal reflux disease: there and back again.
Hirano I
Clin Gastroenterol Hepatol; 2011 Feb; 9(2):99-101. PubMed ID: 21070874
[No Abstract] [Full Text] [Related]
70. [Therapy of gastric acid-induced illnesses in general practice. The first pantoprazole generic drug has arrived].
MMW Fortschr Med; 2009 Jan; 151(5):46-7. PubMed ID: 19391415
[No Abstract] [Full Text] [Related]
71. Gastroesophageal reflux disease and asthma: the role of proton pump inhibitors.
Menon MS; Al-Hajji M; Morice A
Chest; 2006 Jun; 129(6):1732; author reply 1732-3. PubMed ID: 16778299
[No Abstract] [Full Text] [Related]
72. Proton-pump inhibitors could be innocent when used concomitantly with clopidogrel.
Horiuchi H
Circ J; 2012; 76(11):2542-3. PubMed ID: 23001019
[No Abstract] [Full Text] [Related]
73. Omeprazole in oesophageal reflux disease.
Dawson R; Manson JM
Lancet; 2000 Nov; 356(9243):1770-1. PubMed ID: 11095286
[No Abstract] [Full Text] [Related]
74. Proton pump inhibitor and selective serotonin reuptake inhibitor therapy for the management of noncardiac chest pain.
Viazis N; Katopodi K; Karamanolis G; Denaxas K; Varytimiadis L; Galanopoulos M; Tsoukali E; Kamberoglou D; Christidou A; Karamanolis DG; Papatheodoridis G; Mantzaris GJ
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1054-1058. PubMed ID: 28628496
[TBL] [Abstract][Full Text] [Related]
75. [Use of pantoprazol for treatment of gastroesophageal reflux disease and NSAID-induced gastropathy].
Pakhomova IG
Eksp Klin Gastroenterol; 2007; (6):110-5. PubMed ID: 18416104
[No Abstract] [Full Text] [Related]
76. Non-cardiac chest pain: prevalence of reflux disease and response to acid suppression in an Asian population.
Mohd H; Qua CS; Wong CH; Azman W; Goh KL
J Gastroenterol Hepatol; 2009 Feb; 24(2):288-93. PubMed ID: 19054255
[TBL] [Abstract][Full Text] [Related]
77. Evaluation of two Japanese regulatory actions using medical information databases: a 'Dear Doctor' letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrel.
Hanatani T; Sai K; Tohkin M; Segawa K; Antoku Y; Nakashima N; Yokoi H; Ohe K; Kimura M; Hori K; Kawakami J; Saito Y
J Clin Pharm Ther; 2014 Aug; 39(4):361-7. PubMed ID: 24661251
[TBL] [Abstract][Full Text] [Related]
78. [Better understanding of combination use of clopidogrel and proton pump inhibitor].
Lin SR
Zhonghua Nei Ke Za Zhi; 2010 Dec; 49(12):993-4. PubMed ID: 21211352
[No Abstract] [Full Text] [Related]
79. GERD in 2010: diagnosis, novel mechanisms of disease and promising agents.
Kandulski A; Malfertheiner P
Nat Rev Gastroenterol Hepatol; 2011 Feb; 8(2):73-4. PubMed ID: 21293505
[TBL] [Abstract][Full Text] [Related]
80. A systematic review of the role of proton pump inhibitors for symptoms of laryngopharyngeal reflux.
Sen P; Georgalas C; Bhattacharyya AK
Clin Otolaryngol; 2006 Feb; 31(1):20-4; discussion 24. PubMed ID: 16441796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
